Article
Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells
2024-04-17
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy targeting CD19 elicits remarkable clinical efficacy in B-cell malignancies, but many patients relapse due to failed expansion and/or progressive loss of CAR-T cells. We recently reported a strategy to potently restimulate CAR-T cells in vivo , enhancing their functionality by administration of a vaccine-like stimulus comprised of surrogate peptide ligands for a CAR l...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f3ca3b36-6866-51cc-88cc-a24b94562a6a
- DOI
- 10.1101/2024.04.16.589780
